initial public offerings (IPOs) trading on American exchanges

Wednesday, June 17, 2026

---Aerospace parts maker Doncasters targets $4.4 billion valuation in US IPO

June 15 (Reuters) - Doncasters is targeting a valuation of up to $4.43 billion in its U.S. initial public offering, ​becoming the latest aerospace firm to test investor appetite for new ‌listings.
The Derby, United Kingdom-based company is seeking up to $746.7 million in the IPO by offering 23.3 million shares priced between $28 and $32 apiece, it said on Monday.

  • Ticker: DPC
  • Exchange: NYSE
  • Target Deal Size: ~ $700 million
  • Share Price Range: $28 to $32
  • Target Valuation: Up to $4.43 billion at the high end of the range
  • Lead Bookrunners: Jefferies and Morgan Stanley

  • The U.S. IPO market ​has gained momentum after a choppy start to the year, with aerospace ​and defense as well as AI infrastructure themes dominating the ⁠lineup since April.


    Doncasters will follow Arxis (ARXS.O), opens new tab and Applied Aerospace & Defense (AADX.N), opens new tab, fellow aerospace parts ​makers that have gone public in New York since April.

    Company Overview
    • History: Founded in 1778 in Sheffield, UK, the company manufactures high-precision alloy components (like turbine blades and vanes) for the "hot zones" of aerospace engines and industrial gas turbines. 
    • Clients: Serves major original equipment manufacturers (OEMs) including GE Aerospace, Honeywell, Pratt & Whitney, and Rolls-Royce. 
    • Financials: In 2025, the company reported revenue of $837 million, though it remains loss-making due to heavy investments in expanding capacity. 

    Tuesday, June 16, 2026

    ==Parabilis Medicines (PBLS) began trading on the Nasdaq on Wed 10 June 26

    Parabilis Medicines is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them.  

    • Sector: Healthcare
    • Industry: Biotechnology
    • Full Time Employees: 145
    • Founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 
    • Formerly known as Fog Pharma
    • Headquartered in Cambridge, Massachusetts
    • https://parabilismed.com/




    Sunday, June 14, 2026

    Orion S.A. (OEC) : 12-year performance

    Orion S.A. (NYSE: OEC), a global specialty chemical company and leading carbon black producer, completed its Initial Public Offering on July 25, 2014. The company raised roughly $350 million, pricing its shares at $18 each. 
    • Sector: Basic Materials
    • Industry: Specialty Chemicals
    • Full Time Employees: 1,639
    • Founded in 1862 
    • Headquartered in Senningerberg, Luxembourg.
    • https://www.orioncarbons.com





    IPO Details
    • Ticker Symbol: OEC (New York Stock Exchange)
    • IPO Date: July 25, 2014
    • Shares Offered: 19.5 million common shares
    • Initial Pricing: $18.00 per share
    • Lead Underwriters: The primary selling shareholders were Kinove Luxembourg Holdings 1 S.à r.l. and affiliates of private equity firms Triton and Rhone Group. 
    The stock experienced historical highs near $32.61 in 2018.